MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Operating Cycle 2011-2026 | ABT
Annual Operating Cycle Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 | 183 | 188 | 161 | 155 | 176 | 181 | 171 | 176 | 155 | 170 | 169 | 164 | 161 | 149 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 188 | 149 | 169 |
Quarterly Operating Cycle Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 190 | 201 | 192 | 194 | 198 | 191 | 194 | 193 | - | 84.6 | 81.7 | 152 | - | 163 | 154 | 162 | - | 181 | 220 | 200 | 59.5 | 179 | 182 | 181 | 60.9 | 171 | 166 | 174 | 63.1 | 184 | 175 | 61.2 | 55.6 | 55.9 | 55.6 | 62.3 | 60.1 | 60.6 | 60.3 | 65.3 | 61.1 | 64.4 | 64.7 | 72.7 | 71.7 | 75.7 | 73.7 | 109 | 123 | 132 | 131 | 132 | 67.6 | 71.4 | 72.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 220 | 55.6 | 123 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M |  USA |
 |
Bruker Corporation
BRKR
|
274 | $ 39.08 | -1.83 % | $ 5.82 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
216 | - | - | $ 16.4 M | USA |
 |
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
156 | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.79 | 3.73 % | $ 559 M |  Israel |
 |
FONAR Corporation
FONR
|
251 | $ 18.49 | -0.38 % | $ 121 M | USA |
 |
AdaptHealth Corp.
AHCO
|
64 | $ 9.41 | -2.39 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
270 | $ 43.34 | -5.35 % | $ 1.35 B | USA |
 |
IRIDEX Corporation
IRIX
|
170 | $ 1.45 | 2.84 % | $ 23.4 M | USA |
 |
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
308 | $ 104.65 | 0.88 % | $ 1.33 B | USA |
 |
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
279 | $ 29.78 | -2.84 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
299 | $ 3.18 | -3.05 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Accuray Incorporated
ARAY
|
233 | $ 0.52 | -5.19 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Pulmonx Corporation
LUNG
|
337 | $ 1.53 | - | $ 59.8 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | Israel |
 |
Medtronic PLC
MDT
|
237 | $ 96.73 | -1.38 % | $ 124 B | USA |
 |
Cytosorbents Corporation
CTSO
|
175 | $ 0.79 | 5.78 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
171 | $ 182.92 | -3.23 % | $ 13.7 B | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
268 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
866 | $ 3.73 | -3.37 % | $ 790 M | USA |
 |
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.96 | -3.54 % | $ 148 M |  France |
 |
NuVasive
NUVA
|
425 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
359 | - | - | $ 217 M | USA |
 |
Orthofix Medical
OFIX
|
318 | $ 13.02 | -2.62 % | $ 516 M |  Curacao |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 73.88 | -3.07 % | $ 109 B | USA |
 |
PAVmed
PAVM
|
16.8 | $ 9.94 | -0.4 % | $ 71.9 M | USA |
 |
Penumbra
PEN
|
378 | $ 340.23 | -0.61 % | $ 13.2 B | USA |